Wei-Wu He - 09 Jan 2026 SCHEDULE 13D/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Filing Manager
Wei-Wu He
Reporting Manager
WEI-WU HE, Ph.D.
Security
CASI Pharmaceuticals, Inc. Ordinary Shares
Symbol
CASI
Shares outstanding
20,761,963 shares
Disclosed Ownership
3,965,535 shares
Ownership
19%
Form type
SCHEDULE 13D/A
Filing time
09 Jan 2026, 06:03:17 UTC
Date of event
09 Jan 2026
Previous filing
18 Dec 2025
Next filing
29 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Wei-Wu He disclosed 19% ownership in CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) on 09 Jan 2026."

Quick Takeaways

  • Wei-Wu He filed SCHEDULE 13D/A for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI).
  • Disclosed ownership: 19%.
  • Date of event: 09 Jan 2026.

What Changed

  • Previous schedule filing date: 18 Dec 2025.
  • Current filing was accepted on 09 Jan 2026, 06:03.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
WEI-WU HE, Ph.D. 19% 3,965,535 2,130,550 1,834,985 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D. 0001542073
HUIYING MEMORIAL FOUNDATION 3.1% 637,644 0 637,644 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./President
EMERGING TECHNOLOGY PARTNERS, LLC 5.3% 1,097,341 0 1,097,341 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./ Managing Member
ETP Global Fund L.P. 3.7% 753,234 0 753,234 EMERGING TECHNOLOGY PARTNERS, LLC General Partner
ETP BIOHEALTH III FUND, L.P. 1.5% 300,000 0 300,000 EMERGING TECHNOLOGY PARTNERS, LLC General Partner
HE Family GRAT 0.5% 100,000 0 100,000 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./Trustee

Sponsored